ESR1 and breast carcinoma: 3.5. Prognosis–Related AR/ER and Residual Tumor Ki67 Cutoff Values in the Non–pCR Population of Luminal B (HER–2 Negative) Breast Cancer Who Underwent Neoadjuvant Therapy